Go figure — one of those trendy espresso martini might save your life someday.
An espresso martini might save your life someday.
Espresso, made from finely ground coffee beans brewed under pressure with hot water, is the basis for lattes, Americanos and other drinks, including theAnd “numerous studies report that … coffee consumption exerts a [protective] action against two of the most common neurodegenerative diseases, i.e., Parkinson′s and Alzheimer′s,” the study authors wrote.
Experts are still untangling the processes that cause Alzheimer’s to develop, but most researchers point to a protein in the brain called tau. To run their experiments, the researchers isolated compounds from store-bought espresso, namely, caffeine, trigonelline, genistein and theobromine.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Starbucks launches immersive coffee experiences, including espresso martini classStarbucks will offer classes to the public where coffee lovers can learn about brewing techniques, the art and science of the beverage, and mixology (including how to make an espresso martini).
Les mer »
Seattle tree activist gains community support to save cedar as work halts on housing develDroplet is on day four of living in a large red cedar tree in Seattle's Wedgwood neighborhood, and the activist said they plan to stay as long as it takes.
Les mer »
Alzheimer’s disease is most common in these US counties, new study findsOlder people in the eastern and southeastern U.S. have the largest prevalence of Alzheimer’s disease, per new research revealed at the Alzheimer’s Association International Conference.
Les mer »
Gene-Editing Tools Pave Way for New Alzheimer's TreatmentsTwo new studies using CRISPR gene editing offer potential new treatments for Alzheimer's disease.
Les mer »
Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskNew research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening.
Les mer »
Second Alzheimer’s drug in pipeline can slow the disease by a few months but with safety riskAnother experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Les mer »